Navigation Links
Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant
Date:11/6/2009

NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.

Boston Scientific had previously disclosed an investigation by the U.S. Attorney's Office in Minneapolis into alleged violations of the Food, Drug, and Cosmetic Act by Guidant. Under the terms of the agreement, Guidant will plead to two misdemeanor charges related to failure to include information in reports to the U.S. Food and Drug Administration (FDA), and Boston Scientific will pay $296 million on behalf of Guidant.

U.S. Generally Accepted Accounting Principles (GAAP) require that this agreement be recorded in the third quarter, as it occurred after the October 19 release of the Company's third quarter financial results and before the filing of the Company's Quarterly Report on Form 10-Q. Accordingly, the Company has updated its financial results for the third quarter and nine months ended September 30, 2009, recording a third quarter charge of $294 million, on both a pre-tax and after-tax basis. This amount represents the $296 million charge associated with the agreement net of a $2 million reversal of a related accrual.

"We are pleased this investigation has been resolved," said Ray Elliott, President and Chief Executive Officer of Boston Scientific. "Guidant and its employees acted in good faith and believed they complied with applicable laws and regulations. We elected to resolve this matter so we could put it behind us and devote our full energies and resources to developing our innovative technologies."

The only products inv
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)...  Lightbeam Health Solutions announced today an agreement ... ACO) to deploy the Lightbeam population health platform ... while reducing costs. Photo - ... Care Organization is the ACO operating entity of ... is to be the premier integrated health care ...
(Date:9/17/2014)... 2014 According to a new ... Battery, Memory Device, Display, & Microprocessor/MCU), by Application (Imaging, ... by Geography - Global Forecast to 2020", published by ... expected to reach $56.50 Billion by 2020, growing at ... Browse 235 market data Tables and 71 Figures ...
(Date:9/17/2014)... , Sept. 17, 2014 Women everywhere ... infections are not only uncomfortable, they,re often also embarrassing ... plans. pH-D Feminine Health Support ( http://ph-defense.com ) is ... It is an all-natural, homeopathic product. ... common symptoms of vaginal infection. In many cases, the ...
Breaking Medicine Technology:Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4New Product from Vireo Systems: pH-D Feminine Health Support 2
... MELBOURNE, Australia, September 12, 2011   ... Spinifex Pharmaceuticals, an Australian pain drug development company, today ... EMA401 in a model of diabetic neuropathy. EMA401 is an ... development for a number of neuropathic pain indications. ...
... WASHINGTON, Pa., Sept. 10, 2011 Core Essence Orthopaedics, ... tissue and skeletal repair of the extremities, has introduced ... the 66th Annual Meeting of the American Society for ... a pioneer of surgical innovation to the upper and ...
Cached Medicine Technology:New Data on EMA401 in Model of Diabetic Neuropathy Presented at 21st Annual NEURODIAB Meeting 2New Data on EMA401 in Model of Diabetic Neuropathy Presented at 21st Annual NEURODIAB Meeting 3Core Essence Orthopaedics Unveiled New Flexor Tendon Repair System at ASSH 2011 2
(Date:9/17/2014)... the very healthy. Astronauts are selected for their ... standards to prepare them for any unknown challenges. ... people can now fly for enjoyment. The aerospace ... what medical conditions or diseases should be considered ... medical conditions have never been studied for risk ...
(Date:9/17/2014)... who struggle to distinguish between a business strategy and business ... the answer by reading Per Wickstrom’s latest blog post. , ... plan and a business strategy are both strategic – and ... I view it is that a business plan is part ... , According to the blog post, a business plan ...
(Date:9/17/2014)... nanoparticles, gene manipulation these sound like the ... fact, they are components of an exciting new ... preclinical animal models of metastatic prostate cancer, scientists ... Institute of Molecular Medicine and Johns Hopkins Medical ... imaging approach that could revolutionize doctors, ability to ...
(Date:9/17/2014)... Somerset, N.J. (PRWEB) September 17, 2014 ... of advanced delivery technologies and development solutions for ... the launch of OptiPact™, an integrated service and ... roller compaction, and provided from the company’s 450,000 ... technology describes Catalent’s ability to integrate optimal formulation, ...
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- Positive messages ... some people kick the habit, a new study suggests. ... responded better to "loss-framed" messages about the harmful effects ... quit whenever they want benefit more from "gain-framed," or ... The researchers concluded that using a mix of ...
Breaking Medicine News(10 mins):Health News:Space: The final frontier… open to the public 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:New OptiPact™ Technology Introduced by Catalent 2Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2
... promise for human protection in future , , MONDAY, Jan. 28 (HealthDay ... one day ward off the flu. , Not only would the ... it also appears to be more effective than the flu shot ... the potential to be widely accepted by people who are afraid ...
... University researchers is the first to conduct a genome-wide ... contribute to DNA mutations, which are implicated in cancer ... professor of biology Kateryna Makova, the group investigated the ... increase the susceptibility to mutations of microsatellites -- variable-length ...
... ARLINGTON, Va., Jan. 28 Noting recent crises,involving the ... of a governmental blue ribbon panel, Jim Martin, president ... Drug Administration "itself a,threat to the health and safety ... holding hearings on the state of the,FDA on January ...
... Jan. 28 The American Academy of,Pediatrics (AAP) is ... for Thursday, January 31. As reported in The New ... court that a vaccine caused a,child,s autism. While the ... autism and vaccines, the episode,s conclusion delivers a,contrary impression; ...
... of the National Institute of Child Health and Human ... for Reproduction and Infertility Research at the University of ... at expanding the science underlying the success or failure ... reproductive health. , The NICHD supports a national ...
... cancer of the pancreas increase dramatically for patients whose tumors ... Saint Louis University and the M.D. Anderson Cancer Center in ... between tumor size and survival rates for one of the ... the current edition of Pancreas ( www.pancreasjournal.com ) vividly ...
Cached Medicine News:Health News:Drop of Flu Vaccine Under Tongue Bars Infection 2Health News:Scientists explore factors contributing to DNA mutations 2Health News:Scientists explore factors contributing to DNA mutations 3Health News:Scientists explore factors contributing to DNA mutations 4Health News:Don't Overburden FDA 2Health News:American Academy of Pediatrics Calls for Cancellation of ABC's 'Eli Stone' Premiere 2Health News:National Institutes of Health funds new center for reproduction and infertility research at Illinois 2Health News:Pancreatic cancer: The smaller the tumor, the better your chances, study shows 2Health News:Pancreatic cancer: The smaller the tumor, the better your chances, study shows 3
... Medical's line of Personal ... catheters you would choose ... product configurations - standard, ... hydro - are based ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
... Medical's line of Personal ... catheters you would choose ... product configurations - standard, ... hydro - are based ...
Medicine Products: